WANG Yu, ZHANG Feng-ling, CHEN Jia-ying. Study on factors affecting medication compliance in children with attention deficit hyperactivity disorder[J]. journal1, 2011, 19(10): 946-948.
[1] Shen YC, Wang YF, Yang XL. An epidemiological investigation of minimal brain dysfunction in six elementary schools in Beijing[J]. J Child Psychol Psychiatry, 1985, 26: 777-787. [2] Hu YZ. Subtyping and inquiring for etiology of children ADHD aged 6 to 12 years[J]. Chin J School Doctor, 1998, 12: 321-324. [3] Todd RD, Huang H, Henderson CA. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11[J]. Child Psychol Psychiatry, 2008,49(9):942-949. [4] Goodman DW.The consequences of attention-deficit/hyperactivity disorder in adults[J]. J Psychiatr Pract, 2007,13(5):318-327. [5] 金星明.注意缺陷多动障碍的药物治疗[J].中国实用儿科杂志, 2005,20(6):526-528. [6] 钱秋瑾,王玉凤,杜亚松,等.盐酸哌甲酯控释片治疗注意缺陷多动障碍的多中心、随机、双盲、交叉对照研究[J].中华精神科杂志,2005,38(2):90-94. [7] AAP.Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorde[J].Pediatrics,2001,108(4):1033-1044. [8] Brown RT, Amler RW, Freeman WS, et al.Treatment ofaattention-deficit/hyperactivity disorder: overview of the evidence[J]. Pediatrics,2005,115(6):749-757. [9] Pritchard D.Attention deficit hyperactivity disorder in children[J]. Clin Evid,2006,15:331-344. [10] Silva RR.Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children[J].Drugs, 2006,66(8):1127-1128. [11] Faraone SV, Spencer T, Aleardi M, et al. Meta-analysisof the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder[J]. J Clin Psychopharmaco, 2004, 24: 24-29. [12] Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update[J]. Pharmacotherapy, 2009,29(6):656-679. [13] Kuntisi J, Mcloughlin G, Asherson P. Attention deficit hyperactivity disorder[J]. Neuro Molecular Medicine, 2006, 8: 461-484.